Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view DOI Open Access
Julia Martı́n, Noelia Tena, Agustín G. Asuero

et al.

Microchemical Journal, Journal Year: 2021, Volume and Issue: 167, P. 106305 - 106305

Published: April 19, 2021

Language: Английский

Graphene oxide-graphene Van der Waals heterostructure transistor biosensor for SARS-CoV-2 protein detection DOI
Jianwei Gao, Chunhua Wang, Yujin Chu

et al.

Talanta, Journal Year: 2021, Volume and Issue: 240, P. 123197 - 123197

Published: Dec. 31, 2021

Language: Английский

Citations

64

CRISPR-Cas12a-mediated label-free electrochemical aptamer-based sensor for SARS-CoV-2 antigen detection DOI
Na Liu, Ran Liu, Jingjing Zhang

et al.

Bioelectrochemistry, Journal Year: 2022, Volume and Issue: 146, P. 108105 - 108105

Published: March 20, 2022

Language: Английский

Citations

61

SARS‐CoV‐2 RNA Detection by a Cellphone‐Based Amplification‐Free System with CRISPR/CAS‐Dependent Enzymatic (CASCADE) Assay DOI Open Access
Filipe S. R. Silva, Eda Erdogmus,

Ahmed Shokr

et al.

Advanced Materials Technologies, Journal Year: 2021, Volume and Issue: 6(12)

Published: July 19, 2021

CRISPR (Clustered regularly interspaced short palindromic repeats)-based diagnostic technologies have emerged as a promising alternative to accelerate delivery of SARS-CoV-2 molecular detection at the point need. However, efficient translation CRISPR-diagnostic field application is still hampered by dependence on target amplification and reliance fluorescence-based results readout. Herein, an amplification-free CRISPR/Cas12a-based technology for RNA presented using smartphone camera This method, termed Cellphone-based system with CRISPR/CAS-dependent enzymatic (CASCADE) assay, relies mobile phone imaging catalase-generated gas bubble signal within microfluidic channel does not require any external hardware optical attachments. Upon specific reverse-transcribed DNA/RNA heteroduplex (orf1ab) ribonucleoprotein complex, transcleavage collateral activity Cas12a protein Catalase:ssDNA probe triggers system. High analytical sensitivity in without previous (down 50 copies µL

Language: Английский

Citations

59

CRISPR/Cas12a-based biosensor for colorimetric detection of serum prostate-specific antigen by taking nonenzymatic and isothermal amplification DOI
Wanhe Wang, Jingqi Liu, Xiaoxia Li

et al.

Sensors and Actuators B Chemical, Journal Year: 2021, Volume and Issue: 354, P. 131228 - 131228

Published: Dec. 9, 2021

Language: Английский

Citations

59

CRISPR/Cas Systems‐Inspired Nano/Biosensors for Detecting Infectious Viruses and Pathogenic Bacteria DOI
Xianlong Zhang,

Yiheng Shi,

Guang Chen

et al.

Small Methods, Journal Year: 2022, Volume and Issue: 6(10)

Published: Sept. 16, 2022

Abstract Infectious pathogens cause severe human illnesses and great deaths per year worldwide. Rapid, sensitive, accurate detection of is importance for preventing infectious diseases caused by optimizing medical healthcare systems. Inspired a microbial defense system (i.e., CRISPR/ CRISPR‐associated proteins (Cas) system, an adaptive immune protecting microorganisms from being attacked invading species), many new biosensors have been successfully developed widely applied in the viruses pathogenic bacteria. Moreover, advanced nanotechnologies also integrated into these to improve their stability, sensitivity, accuracy. In this review, recent advance CRISPR/Cas systems‐based nano/biosensors applications bacteria are comprehensively reviewed. First all, categories working principles systems establishing simply introduced. Then, design construction discussed. end, attentions focused on Impressively, remaining opportunities challenges further development system‐based promising proposed.

Language: Английский

Citations

48

Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments DOI
Niaz Mahmud, Muzahidul I. Anik, M. Khalid Hossain

et al.

ACS Applied Bio Materials, Journal Year: 2022, Volume and Issue: 5(6), P. 2431 - 2460

Published: May 18, 2022

The COVID-19 pandemic caused by the SARS-CoV-2, a ribonucleic acid (RNA) virus that emerged less than two years ago but has nearly 6.1 million deaths to date. Recently developed variants of SARS-CoV-2 have been shown be more potent and expanded at faster rate. Until now, there is no specific effective treatment for in terms reliable sustainable recovery. Precaution, prevention, vaccinations are only ways keep situation under control. Medical scientific professionals now focusing on repurposing previous technology trying develop fruitful methodologies detect presence viruses, treat patients, precautionary items, vaccine developments. Nanomedicine or nanobased platforms can play crucial role these fronts. Researchers working many approaches nanosized particles combat SARS-CoV-2. platform extremely diverse (i.e., mark personal protective suit, rapid diagnostic tool targeted treatment, developments). Although theoretical possibilities until an inadequate number research targeting explore such scenarios. This unique mini-review aims compile elaborate recent advances from diagnostics, developments against associated challenges.

Language: Английский

Citations

46

Current Advances in Paper-Based Biosensor Technologies for Rapid COVID-19 Diagnosis DOI Open Access
Soohyun Kim,

Jong‐Hwan Lee

BioChip Journal, Journal Year: 2022, Volume and Issue: 16(4), P. 376 - 396

Published: Aug. 10, 2022

Language: Английский

Citations

46

Glow-in-the-Dark Infectious Disease Diagnostics Using CRISPR-Cas9-Based Split Luciferase Complementation DOI Creative Commons
Harmen J. van der Veer, Eva A. van Aalen, Claire M. S. Michielsen

et al.

ACS Central Science, Journal Year: 2023, Volume and Issue: 9(4), P. 657 - 667

Published: March 15, 2023

Nucleic acid detection methods based on CRISPR and isothermal amplification techniques show great potential for point-of-care diagnostic applications. However, most current rely fluorescent or lateral flow assay readout, requiring external excitation postamplification reaction transfer. Here, we developed a bioluminescent nucleic sensor (LUNAS) platform in which target dsDNA is sequence-specifically detected by pair of dCas9-based probes mediating split NanoLuc luciferase complementation. LUNAS easily integrated with recombinase polymerase (RPA), providing attomolar sensitivity rapid one-pot assay. A calibrator included robust ratiometric enabling real-time monitoring the RPA using simple digital camera. We designed an RT-RPA-LUNAS that allows SARS-CoV-2 RNA without need cumbersome isolation demonstrated its performance COVID-19 patient nasopharyngeal swab samples. Detection from samples viral loads ∼200 cp/μL was achieved within ∼20 min, showing RPA-LUNAS attractive infectious disease testing.

Language: Английский

Citations

32

Highly sensitive and facile microRNA detection based on target triggered exponential rolling-circle amplification coupling with CRISPR/Cas12a DOI
Shiying Zhou,

Human Sun,

Jiangbo Dong

et al.

Analytica Chimica Acta, Journal Year: 2023, Volume and Issue: 1265, P. 341278 - 341278

Published: April 30, 2023

Language: Английский

Citations

28

Recent progress in nucleic acid detection with CRISPR DOI Open Access

Frank X. Liu,

Johnson Q. Cui, Zhihao Wu

et al.

Lab on a Chip, Journal Year: 2023, Volume and Issue: 23(6), P. 1467 - 1492

Published: Jan. 1, 2023

Critical development of CRISPR-based diagnostics coupled with nucleic acid amplification and amplification-free techniques; various purposes CRISPR including determination, quantification, multiplexed point-of-care diagnostics.

Language: Английский

Citations

23